We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medicines Company | NASDAQ:MDCO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.90 | 84.00 | 84.94 | 0 | 01:00:00 |
The Medicines Company
|
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
|
000-31191
|
|
04-3324394
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
8 Sylvan Way
|
|
07054
|
||
Parsippany
|
,
|
New Jersey
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
(Former Name or Former Address, if Changed Since Last Report)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
MDCO
|
NASDAQ Global Select Market
|
99.1
|
Press release dated October 30, 2019 entitled “The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran”
|
Exhibit No.
|
Description
|
Press release dated October 30, 2019 entitled “The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran”
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
1 Year Medicines Chart |
1 Month Medicines Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions